Transcription Factors: From Oncogenesis to Druggable Targets of Natural Products
Guest Editor: Siddavaram Nagini Department of Biochemistry, Annamalai University, Tamil Nadu, India
Aims & Scope:
Transcription factors are vital components of complex signalling networks that regulate a plethora of diverse cellular processes including cell division, differentiation, migration, cell death, and homeostasis. The human transcription factor repertoire of over 1600 proteins act individually or as an ensemble to recognize specific DNA sequences and regulate gene expression. Aberrant expression of transcription factors contributes to dysregulated signalling and acquisition of hallmark capabilities of cancer. There is mounting evidence to indicate that transcription factors such as NF-κB, β-catenin, c-Myc, AP-1, Nrf2, HIF-1α, and STAT-3 are potential druggable targets of natural products. This thematic issue will focus on the role of transcription factors in oncogenesis and as potential molecular targets for intervention by natural products. Review articles will provide mechanistic insights on phytochemicals and analogues targeting transcription factors by innovative approaches that could impact cancer therapeutics as well as the challenges and limitations.
The subtopics to be covered within this issue include:
Mechanisms of altered transcription factor activity in cancer and modulation by natural products.
Impact of transcription factor targeting by natural products on oncogenic signalling and cancer hallmarks.
Innovative approaches to target transcription factor activity in malignant tumours by natural products.
Structure-activity relationship in transcription factor targeting by natural products and their analogues.
Challenges and opportunities in developing drugs from natural products that target transcription factors.
Jia Zhou Chemical Biology Program Department of Pharmacology and Toxicology University of Texas Medical Branch Galveston, TX (USA) Biography
Biography of Jia Zhou
Dr. Jia Zhou is currently a tenured Professor in the Chemical Biology Program at University of Texas Medical Branch (UTMB), USA. He was educated with a PhD degree and trained as a postdoctoral research fellow from Nankai University, University of Virginia, and Georgetown University Medical Center, respectively. He has over 20 years of research experience in medicinal chemistry, drug discovery and development including 7 years of industrial experience in pharmaceuticals. Dr. Zhou’s research interest is drug discovery and development of novel small molecules as potential therapeutics for the treatment of central nervous system (CNS) disorders, cancer, inflammation, and infectious diseases. He is an author of more than 190 papers, 7 book chapters and an inventor of 26 patents. He is also a National Academy of Inventors (NAI) Fellow.
Current Topics in Medicinal Chemistry was introduced in 2001 with the assistance of Dr. Allen B. Reitz, who served as the editor-in-chief from 2001 to 2020. Currently, Dr. Jia Zhou is the Editor-in-Chief of the journal.